Dr. Kazempour, President and CEO at Amarex Clinical Research, will be a guest speaker at the 10th Annual Congress of International Drug Discovery Science and Technology (IDDST) in Nanjing, China

Amarex receives 2012 Best of Germantown Award

Dr. Kazempour, President and CEO at Amarex Clinical Research and the Senior Director of Amarex Regulatory Affairs and Quality Assurance, Dr. Kumar, attends the annual meeting of the Diabetic Neuropathy Study Group in Dresden, Germany

bioLytical Laboratories (BC, Canada) received a CLIA waiver from the FDA for their INSTI HIV-1 Antibody Test, opening the door for a wider range of laboratory facilities to administer the test.